Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.48 USD
Change Today +0.01 / 0.29%
Volume 950.5K
SQNM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - sequenom inc (SQNM)

Name (Connections)Board RelationshipsTitleKey Developments
John Fazio 36 RelationshipsDirector and Chairman of Audit CommitteeSEQUENOM Announces Restatement of Financial Statements for the period ended June 30, 2002
01/31/03
Charles Slacik CPA 28 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit CommitteeSequenom Inc. announced delayed annual 10-K filing
03/18/13
David Pendarvis 21 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeSequenom Inc. Receives Investigation Notification from Securities And Exchange Commission
06/30/09

Compensation Committee* - sequenom inc (SQNM)

Name (Connections)Board RelationshipsTitle
Kenneth Buechler Ph.D. 65 RelationshipsChairman, Chairman of Science Committee and Member of Compensation Committee
Richard Lerner M.D. 239 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Science Committee
Charles Slacik CPA 28 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
SQNM Compensation vs. Industry
433.0K
405.5K
Chief Executive Officer
343.9K
321.3K
Chief Financial Officer
Share price activity for SEQUENOM INC (SQNM)
52 Week Price Performance
SQNM
Industry Average

Nominating Committee* - sequenom inc (SQNM)

Name (Connections)Board RelationshipsTitleKey Developments
Myla Lai-Goldman Ph.D., M.D. 60 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Science CommitteeSequenom Inc. Announces Board Changes
03/17/15
Richard Lerner M.D. 239 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Science CommitteeSequenom Inc. Announces Board Changes, Effective April 1, 2015
03/16/15
David Pendarvis 21 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeJohn A. Fazio Not to Stand for Reelection to the Board of Sequenom Inc
01/23/15

Corporate Governance Committee* - sequenom inc (SQNM)

Name (Connections)Board RelationshipsTitle
Myla Lai-Goldman Ph.D., M.D. 60 RelationshipsChairman, Chairman of Science Committee and Member of Compensation Committee
Richard Lerner M.D. 239 RelationshipsLead Independent Director, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Science Committee
David Pendarvis 21 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
SQNM and Competitor
Insiders vs. External
Board
9%
91%
Sequenom Inc.
29%
71%
Cerus Corporation
13%
87%
STAAR Surgical Company
14%
86%
SurModics, Inc.
22%
78%
AtriCure, Inc.
5%
95%
Pacific Biosciences of California, Inc.
Insiders
External Board Members

Advisory Committee* - sequenom inc (SQNM)

Name (Board Relationships)/Title Board Affiliations
Frank Chervenak 21 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Arnold Cohen 28 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Michal Elovitz 21 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Anne Fung 31 Relationships
Member of Ophthalmology Clinical Advisory Board
No other board affiliations
Karen Gehrs 21 Relationships
Member of Ophthalmology Clinical Advisory Board
No other board affiliations
Gregory Hageman 39 Relationships
Member of Ophthalmology Clinical Advisory Board
No other board affiliations
Jeffrey Heier 71 Relationships
Member of Ophthalmology Clinical Advisory Board
No other board affiliations
Wolfgang Holzgreve 21 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Suber Huang 21 Relationships
Member of Ophthalmology Clinical Advisory Board
No other board affiliations
Dennis Lo 21 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Lee Shulman 31 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
Yves Ville 21 Relationships
Member of Prenatal Clinical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQNM:US $3.48 USD +0.01

SQNM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $22.38 USD +0.57
Cerus Corp $4.67 USD +0.13
Pacific Biosciences of California Inc $5.59 USD +0.04
STAAR Surgical Co $9.42 USD +0.27
SurModics Inc $24.80 USD +0.42
View Industry Companies
 

Industry Analysis

SQNM

Industry Average

Valuation SQNM Industry Range
Price/Earnings 26.6x
Price/Sales 2.7x
Price/Book NM Not Meaningful
Price/Cash Flow 13.2x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.